BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction

American Journal of Physiology - Renal Physiology

Volumn 292, Issue 2, 2007, Pages

  Djamali, Arjang ^a,b   Sadowski, Elizabeth A ^b   Muehrer, Rebecca J ^a   Reese, Shannon ^a   Smavatkul, Chanigan ^a   Vidyasagar, Aparna ^a   Fain, Sean B ^b   Lipscomb, Ryan C ^b   Hullett, Debra H ^a   Samaniego Picota, Millie ^a   Grist, Thomas M ^b   Becker, Bryan N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Blood oxygen level dependent magnetic resonance imaging; Deoxyhemoglobin; Transplant

Indexed keywords

ALEMTUZUMAB; ANTIOXIDANT; BASILIXIMAB; BIOLOGICAL MARKER; CYCLOSPORIN A; DEOXYHEMOGLOBIN; HEAT SHOCK PROTEIN 27; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; OXYHEMOGLOBIN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY; KIDNEY CORTEX; KIDNEY GRAFT REJECTION; KIDNEY MEDULLA; KIDNEY TRANSPLANTATION; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; OXYGENATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 33846859143     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00222.2006     Document Type: Article

References (76)

1. Abe M, O'Connor P, Kaldunski ML, Liang M, Roman RJ, Cowley AW Jr. Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol 291: F350-F357, 2006.
2. Abid MR, Razzaque MS, Taguchi T. Oxidant stress in renal pathophysiology. Contrib Nephrol 148: 135-153, 2005.
3. Adler S, Huang H, Wolin MS, Kaminski PM. Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J Am Soc Nephrol 15: 52-60, 2004.
4. Albrecht EW, Stegeman CA, Tiebosch AT, Tegzess AM, van Goor H. Expression of inducible and endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure. Am J Transplant 2: 448-453, 2002.
5. Alford SK, Sadowski EA, Unal O, Polzin JA, Consigny DW, Korosec FR, Grist TM. Detection of acute renal ischemia in swine using blood oxygen level-dependent magnetic resonance imaging. J Magn Reson Imaging 22: 347-353, 2005.
6. Amuchastegui SC, Azzollini N, Mister M, Pezzotta A, Perico N, Remuzzi G. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9: 1948-1955, 1998.
7. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50: 1110-1117, 1996.
8. Anonymous. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39: S1-S246, 2002.
9. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 332: 647-655, 1995.
10. Campise M, Bamonti F, Novembrino C, Ippolito S, Tarantino A, Cornelli U, Lonati S, Cesana BM, Ponticelli C. Oxidative stress in kidney transplant patients. Transplantation 76: 1474-1478, 2003.
11. Campistol JM, Inigo P, Larios S, Bescos M, Oppenheimer F. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrol Dial Transplant 16, Suppl 1: 114-116, 2001.
12. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
13. Colvin RB. Chronic allograft nephropathy. N Engl J Med 349: 2288-2290, 2003.
14. Cristol JP, Vela C, Maggi MF, Descomps B, Mourad G. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 65: 1322-1328, 1998.
15. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288: 2008-2014, 2002.
16. de Cavanagh EM, Piotrkowski B, Fraga CG. Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging. Mol Aspects Med 25: 27-36, 2004.
17. Djamali A, Premasathian N, Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol 23: 306-316, 2003.
18. Djamali A, Reese S, Oberley T, Hullett D, Becker B. Heat shock protein 27 in chronic allograft nephropathy: a local stress response. Transplantation 79: 1645-1657, 2005.
19. Djamali A, Reese S, Yracheta J, Oberley T, Hullett D, Becker B. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 5: 500-509, 2005.
20. Djamali A, Sadowski EA, Samaniego-Picota M, Fain SB, Muehrer RJ, Alford SK, Grist TM, Becker BN. Noninvasive assessment of early kidney allograft dysfunction by blood oxygen level-dependent magnetic resonance imaging. Transplantation 82: 621-628, 2006.
21. Eppel GA, Malpas SC, Denton KM, Evans RG. Neural control of renal medullary perfusion. Clin Exp Pharmacol Physiol 31: 387-396, 2004.
22. Epstein FH. Oxygen and renal metabolism. Kidney Int 51: 381-385, 1997.
23. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 57: 2080-2083, 2000.
24. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care 25: 575-578, 2002.
25. Evans RG, Eppel GA, Anderson WP, Denton KM. Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22: 1439-1451, 2004.
26. Evans RG, Fitzgerald SM. Nitric oxide and superoxide in the renal medulla: a delicate balancing act. Curr Opin Nephrol Hypertens 14: 9-15, 2005.
27. Gabriels G, August C, Grisk O, Steinmetz M, Kosch M, Rahn KH, Schlatter E. Impact of renal transplantation on small vessel reactivity. Transplantation 75: 689-697, 2003.
28. Grisk O, Grone HJ, Rose HJ, Rettig R. Sympathetic reinnervation of rat kidney grafts. Transplantation 72: 1153-1155, 2001.
29. Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 14: S246-S249, 2003.
30. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett 486: 10-13, 2000.
31. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60: 358-363, 2001.
32. Huot J, Houle F, Spitz DR, Landry J. HSP27 phosphorylation- mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 56: 273-279, 1996.
33. Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 67: 321-332, 2005.
34. Ishii Y, Sawada T, Kubota K, Fuchinoue S, Teraoka S, Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 67: 321-332, 2005.
35. Juillard L, Lerman LO, Kruger DG, Haas JA, Rucker BC, Polzin JA, Riederer SJ, Romero JC. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int 65: 944-950, 2004.
36. Kaplan B, Meier-Kriesche HU. Renal transplantation: a half century of success and the long road ahead. J Am Soc Nephrol 15: 3270-3271, 2004.
37. Keith DS, DeMattos A, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J Am Soc Nephrol 16: 1512-1521, 2005.
38. Khan W, McGuirt JP, Sens MA, Sens DA, Todd JH. Expression of heat shock protein 27 in developing and adult human kidney. Toxicol Lett 84: 69-79, 1996.
39. Kone BC. Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health. Semin Nephrol 24: 299-315, 2004.
40. Kone BC. A 'BOLD' new approach to renal oxygen economy. Circulation 94: 3067-3068, 1996.
41. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245, 2003.
42. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999.
43. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 93: 11853-11858, 1996.
44. Mas V, Alvarellos T, Giraudo C, Massari P, De Boccardo G, Campistol JM, Inigo P, Larios S, Bescos M, Oppenheimer F. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Transplantation 74: 718-721, 2002.
45. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4: 1289-1295, 2004.
46. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004.
47. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA III, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328-2334, 2004.
48. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del VC, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106: 2800-2805, 2002.
49. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24: 354-365, 2004.
50. Muller E, Neuhofer W, Ohno A, Rucker S, Thurau K, Beck FX. Heat shock proteins HSP25, HSP60, HSP72, HSP73 in isoosmotic cortex and hyperosmotic medulla of rat kidney. Pflügers Arch 431: 608-617, 1996.
51. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003.
52. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65: 1009-1016, 2004.
53. Pallone TL. Is oxidative stress differentially regulated in the renal cortex and medulla? Nat Clin Pract Nephrol 2: 118-119, 2006.
54. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590, 2002.
55. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17: 2309-2315, 1997.
56. Pauling L, Coryell CD. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA 22: 210-216, 1936.
57. Pedersen M, Dissing TH, Morkenborg J, Stodkilde-Jorgensen H, Hansen LH, Pedersen LB, Grenier N, Frøkiær J. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int 67: 2305-2312, 2005.
58. Prasad PV, Chen Q, Goldfarb JW, Epstein FH, Edelman RR. Breathhold R2* mapping with a multiple gradient-recalled echo sequence: application to the evaluation of intrarenal oxygenation. J Magn Reson Imaging 7: 1163-1165, 1997.
59. Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 94: 3271-3275, 1996.
60. 2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int 55: 294-298, 1999.
61. Preville X, Schultz H, Knauf U, Gaestel M, Arrigo AP. Analysis of the role of Hsp25 phosphorylation reveals the importance of the oligomerization state of this small heat shock protein in its protective function against TNFalpha- and hydrogen peroxide-induced cell death. J Cell Biochem 69: 436-452, 1998.
62. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 4: 1562-1566, 2004.
63. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y. The Banff 97 working classi-fication of renal allograft pathology. Kidney Int 55: 713-723, 1999.
64. Raj DS, Lim G, Levi M, Qualls C, Jain SK. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy. Am J Kidney Dis 43: 154-160, 2004.
65. Sadowski EA, Fain SB, Alford SK, Korosec FR, Fine J, Muehrer R, Djamali A, Hofmann RM, Becker BN, Grist TM. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience. Radiology 236: 911-919, 2005.
66. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, promises. N Engl J Med 351: 2761-2766, 2004.
67. Schwenger V, Korosoglou G, Hinkel UP, Morath C, Hansen A, Sommerer C, Dikow R, Hardt S, Schmidt J, Kucherer H, Katus HA, Zeier M. Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant 6: 609-615, 2006.
68. Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79: 914-919, 2005.
69. Simon-Zoula SC, Hofmann L, Giger A, Vogt B, Vock P, Frey FJ, Boesch C. Non-invasive monitoring of renal oxygenation using BOLDMRI: a reproducibility study. NMR Biomed 19: 84-89, 2006.
70. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422, 1993.
71. Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 714: 265-270, 1982.
72. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93-99, 2004.
73. Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Salvatore F, Berruti V, Gandolfo MT, Garibotto G, Deferrari G. Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. J Am Soc Nephrol 15, Suppl 1: S85-S87, 2004.
74. Vos IH, Joles JA, Rabelink TJ. The role of nitric oxide in renal transplantation. Semin Nephrol 24: 379-388, 2004.
75. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999.
76. Yuen JW, Benzie IF. Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress. Free Radic Res 37: 1209-1213, 2003.